ÈËÆÞÖгöÊÓƵ

Skip to main content
Bogdana Schmidt
( out of 176 reviews )

Bogdana Schmidt, MD, MPH

Languages spoken: English, Russian, Spanish, Ukrainian

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 2B, Urology
Salt Lake City
801-587-4381

Veterans Administration Medical Center

Salt Lake City
  • Bogdana Schmidt, MD, MPH, is a urologic surgeon at the ÈËÆÞÖгöÊÓƵ of Utah in Salt Lake City, Utah. Dr. Schmidt specializes in urologic oncology. She attended ÈËÆÞÖгöÊÓƵ of San Francisco, School of Medicine and stayed to complete her residency training there. She then completed a Society of Urologic Oncology fellowship at Stanford ÈËÆÞÖгöÊÓƵ.

    Dr. Schmidt’s clinical interests include:

    • The treatment of bladder cancer, kidney cancer, prostate cancer, testis cancer, and penile cancer.

    • Novel imaging technologies

    • Organ preservation

    • Minimally invasive/robotic urology procedures.

    Dr. Schmidt’s research interests focus on:

    • Improving patient risk stratification and optimization of surgical outcomes

    • Quality improvement in urologic oncology

    • Addressing health disparities in urologic oncology

    • The integration of artificial intelligence and advanced imaging techniques into urologic care

    Patient Rating

    4.9 /5
    ( out of 176 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 31, 2024
    HUNTSMAN CANCER CENTER

    fabulous doctor, truly cares and listens intently, excellent about explaining things to you, very respectful of your opinion and feelings, could not have a better physician to manage care, never feels like she is in a hurry and is very patient, extremely knowledgeable and concerned about your situation and health and fears. She instills confidence and hope in you by her calm and concerned demeanor. Would not consider anyone else to treat my issues.

    October 30, 2024
    HUNTSMAN CANCER CENTER

    I am so blessed to have Doctor Schmidt as my doctor. From day one she was very much in touch with my concerns and outcome with my cancer.

    October 29, 2024
    HUNTSMAN CANCER CENTER

    She is very knowledgeable and personable. I feel very comfortable speaking with her. I'm so glad we were referred to her.

    October 29, 2024
    HUNTSMAN CANCER CENTER

    Dr. Schmidt has provided excellent and compassionate care for me during this difficult time. I recommend her without hesitation.

    October 29, 2024
    HUNTSMAN CANCER CENTER

    Dr. Schmidt is amazing! She is very compassionate and caring! She answered all my questions and provided great feedback! Very respectful and kind!! I can't thank her enough for her service and support!!

    October 16, 2024
    HUNTSMAN CANCER CENTER

    Dr. Schmidt is caring and professional, very glad to have her for my care.

    October 03, 2024
    HUNTSMAN CANCER CENTER

    Dr. Schmidt is excellent. I've been very pleased with my surgery and follow up. She is kind, professional and capable.

    October 02, 2024
    HUNTSMAN CANCER CENTER

    Very efficient and informative

    September 20, 2024
    HUNTSMAN CANCER CENTER

    The procedures to me were not the procedures I experienced. But I don't blame that on Dr. Schmidt. I could explain at a later time.

  • Bogdana Schmidt, MD, MPH, is a urologic surgeon at the ÈËÆÞÖгöÊÓƵ of Utah in Salt Lake City, Utah. Dr. Schmidt specializes in urologic oncology. She attended ÈËÆÞÖгöÊÓƵ of San Francisco, School of Medicine and stayed to complete her residency training there. She then completed a Society of Urologic Oncology fellowship at Stanford ÈËÆÞÖгöÊÓƵ.

    Dr. Schmidt’s clinical interests include:

    • The treatment of bladder cancer, kidney cancer, prostate cancer, testis cancer, and penile cancer.

    • Novel imaging technologies

    • Organ preservation

    • Minimally invasive/robotic urology procedures.

    Dr. Schmidt’s research interests focus on:

    • Improving patient risk stratification and optimization of surgical outcomes

    • Quality improvement in urologic oncology

    • Addressing health disparities in urologic oncology

    • The integration of artificial intelligence and advanced imaging techniques into urologic care

    Board Certification and Academic Information

    Academic Departments Surgery -Primary
    Academic Divisions Urology

    Education history

    Fellowship Urologic Oncology - Stanford ÈËÆÞÖгöÊÓƵ Fellow
    Urologic Surgery - ÈËÆÞÖгöÊÓƵ of California, San Francisco Resident
    Internship General Surgery - ÈËÆÞÖгöÊÓƵ of California, San Francisco Intern
    Medicine - ÈËÆÞÖгöÊÓƵ of California, San Francisco School of Medicine M.D.
    Graduate Training Community ÈËÆÞÖгöÊÓƵ Science - ÈËÆÞÖгöÊÓƵ of California, Los Angeles M.P.H.
    Physiological Science - ÈËÆÞÖгöÊÓƵ of California, Los Angeles B.S.

    Selected Publications

    Journal Article

    1. Sung D, Schmidt B, Tward JD (2024). The Ability of the STAR-CAP Staging System to Prognosticate the Risk of Subsequent Therapies and Metastases After Initial Treatment of M0 Prostate Cancer. Clin Genitourin Cancer. ()
    2. Hutten R, Khouri A, Parsons M, Tward A, Wilson T, Peterson J, Morrell G, Dechet C, ONeil B, Schmidt B, Kokeny K, Lloyd S, Cannon D, Tward J, Sanchez A, Johnson S (2022). The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. Clin Genitourin Cancer, 20(6), e453-e459. ()
    3. Schmidt B, Velaer KN, Thomas IC, Ganesan C, Song S, Pao AC, Thong AE, Liao JC, Chertow GM, Skinner EC, Leppert JT (2022). Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer. Eur Urol Open Sci, 35, 29-36. ()
    4. Vilson FL, Schmidt B, White L, Sorensen SJC, Ganesan C, Pao AC, Enemchukwu E, Chertow GM, Leppert JT (2021). Removing Race from eGFR calculations: Implications for Urologic Care. Urology. ()
    5. Schmidt B, Leppert JT (2021). Costs of Robotic-Assisted Radical Prostatectomy 1 Year After Surgery: Pay Now and Save Later? JAMA Netw Open, 4(3), e212548. ()
    6. Schmidt B, Bhambhvani HP, Greenberg DR, Prado K, Shafer S, Thong A, Gill H, Skinner E, Shah JB (2020). Bupivacaine local anesthetic to decrease opioid requirements after radical cystectomy: Does formulation matter? Urol Oncol. ()
    7. Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR (2018). Practice patterns of primary EBRT with and without ADT in prostate cancer treatment. Prostate Cancer Prostatic Dis, 22(1), 117-124. ()
    8. Schmidt B, Meng MV, Hampson LA (2018). Operating Room Supply Cost Awareness: A Cross-Sectional Analysis. Urol Pract, 6(2), 73-78. ()
    9. Truesdale MD, Elmer-Dewitt M, Sandri M, Schmidt B, Metzler I, Gadzinski A, Stoller ML, Chi T (2016). Methylene Blue Injection as an Alternative to Antegrade Nephrostography to Assess Urinary Obstruction After Percutaneous Nephrolithotomy. J Endourol, 30(4), 476-82. ()
    10. Schmidt B, Copp HL (2015). Work-up of Pediatric Urinary Tract Infection. Urol Clin North Am, 42(4), 519-26. ()
    11. Kovshilovskaya B, Chi T, Miller J, Stoller ML (2016). Systemic implications of urinary stone disease. Transl Androl Urol, 1(2), 89-96. ()
    12. Weiss DA, Kovshilovskaya B, Breyer BN (2011). Gender trends of urology manuscript authors in the United States: a 35-year progression. J Urol, 187(1), 253-8. ()
    13. Call GB, Olson JM, Chen J, Villarasa N, Ngo KT, Yabroff AM, Cokus S, Pellegrini M, Bibikova E, Bui C, Cespedes A, Chan C, Chan S, Cheema AK, Chhabra A, Chitsazzadeh V, Do MT, Fang QA, Folick A, Goodstein GL, Huang CR, Hung T, Kim E, Kim W, Kim Y, Kohan E, Kuoy E, Kwak R, Lee E, Lee J, Lin H, Liu HC, Moroz T, Prasad T, Prashad SL, Patananan AN, Rangel A, Rosselli D, Sidhu S, Sitz D, Taber CE, Tan J, Topp K, Tran P, Tran QM, Unkovic M, Wells M, Wickland J, Yackle K, Yavari A, Zaretsky JM, Allen CM, Alli L, An J, Anwar A, Arevalo S, Ayoub D, Badal SS, Baghdanian A, Baghdanian AH, Baumann SA, Becerra VN, Chan HJ, Chang AE, Cheng XA, Chin M, Chong F, Crisostomo C, Datta S, Delosreyes A, Diep F, Ekanayake P, Engeln M, Evers E, Farshidi F, Fischer K, Formanes AJ, Gong J, Gupta R, Haas BE, Hahm V, Hsieh M, Hui JZ, Iao ML, Jin SD, Kim AY, Kim LS, King M, Knudsen-Robbins C, Kohanchi D, Kovshilovskaya B, Ku A, Kung RW, Landig ME, Latterman SS, Lauw SS, Lee DS, Lee JS, Lei KC, Leung LL, Lerner R, Lin JY, Lin K, Lim BC, Lui CP, Liu TQ, Luong V, Makshanoff J, Mei AC, Meza M, Mikhaeil YA, Moarefi M, Nguyen LH, Pai SS, Pandya M, Patel AR, Picard PD, Safaee MM, Salame C, Sanchez C, Sanchez N, Seifert CC, Shah A, Shilgevorkyan OH, Singh I, Soma V, Song JJ, Srivastava N, StaAna JL, Sun C, Tan D, Teruya AS, Tikia R, Tran T, Travis EG, Trinh JD, Vo D, Walsh T, Wong RS, Wu K, Wu YW, Yang NX, Yeranosian M, Yu JS, Zhou JJ, Zhu RX, Abrams A, Abramson A, Amado L, Anderson J, Bashour K, Beyer E, Bookatz A, Brewer S, Buu N, Calvillo S, Cao J, Chan A, Chan J, Chang A, Chang D, Chang Y, Chen Y, Choi J, Chou J, Dang P, Datta S, Davarifar A, Deravanesian A, Desai P, Fabrikant J, Farnad S, Fu K, Garcia E, Garrone N, Gasparyan S, Gayda P, Go S, Goffstein C, Gonzalez C, Guirguis M, Hassid R, Hermogeno B, Hong J, Hong A, Hovestreydt L, Hu C, Huff D, Jamshidian F, Jen J, Kahen K, Kao L, Kelley M, Kho T, Kim Y, Kim S, Kirkpatrick B, Langenbacher A, Laxamana S, Lee J, Lee C, Lee SY, Lee TS, Lee T, Lewis G, Lezcano S, Lin P, Luu T, Luu J, Marrs W, Marsh E, Marshall J, Min S, Minasian T, Minye H, Misra A, Morimoto M, Moshfegh Y, Murray J, Nguyen K, Nguyen C, Nodado E 2nd, ODonahue A, Onugha N, Orjiakor N, Padhiar B, Paul E, Pavel-Dinu M, Pavlenko A, Paz E, Phaklides S, Pham L, Poulose P, Powell R, Pusic A, Ramola D, Regalia K, Ribbens M, Rifai B, Saakyan M, Saarikoski P, Segura M, Shadpour F, Shemmassian A, Singh R, Singh V, Skinner E, Solomin D, Soneji K, Spivey K, Stageberg E, Stavchanskiy M, Tekchandani L, Thai L, Thiyanaratnam J, Tong M, Toor A, Tovar S, Trangsrud K, Tsang WY, Uemura M, Vollmer E, Weiss E, Wood D, Wu J, Wu S, Wu W, Xu Q, Yamauchi Y, Yarosh W, Yee L, Yen G, Banerjee U (2007). Genomewide clonal analysis of lethal mutations in the Drosophila melanogaster eye: comparison of the X chromosome and autosomes. Genetics, 177(2), 689-97. ()

    Commentary

    1. Schmidt B, Agarwal N (2021). Black Men Receiving Radiotherapy for Localized Prostate Cancer Have Improved Outcomes-Clinical Trial Access or Racial Advantage? JAMA Netw Open, 4(12), e2140692. ()

    Case Report

    1. Vilson FL, Lin SY, Schmidt B (2020). Resolution of bilateral testicular masses after viral infection. Urol Case Rep, 33, 101388. ()

    Editorial

    1. Bergman J, Schmidt B, Leppert JT (2020). Following Up on an Improperly Drawn Screening Test: The PSA Dilemma. Am J Med, 134(3), e145-e146. ()
  • News & Podcasts